Association between bronchopulmonary dysplasia and MBL2 and IL1-RN polymorphisms

Pediatrics International

Volumn 54, Issue 6, 2012, Pages 863-868

  Cakmak, Bilin Cetinkaya ^a   Calkavur, Sebnem ^a   Ozkinay, Ferda ^a   Koroglu, Ozge Altun ^a   Onay, Huseyin ^a   Itirli, Gulcin ^b   Karaca, Emin ^a   Yalaz, Mehmet ^a   Akisu, Mete ^a   Kultursay, Nilgün ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b IZMIR UNIVERSITY   (Turkey)

Author keywords

Bronchopulmonary dysplasia; Gene polymorphism; Interleukin 1 receptor antagonist; Mannose binding lectin; Preterm

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LUNG SURFACTANT; MANNOSE BINDING LECTIN 2;

ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; INFANT; LOW BIRTH WEIGHT; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; NEWBORN INFECTION; PREMATURITY; PRIORITY JOURNAL; RISK FACTOR;

BRONCHOPULMONARY DYSPLASIA; DNA; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MANNOSE-BINDING LECTIN; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RETROSPECTIVE STUDIES;

EID: 84872764334     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2012.03714.x     Document Type: Article

References (33)

1. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 2001; 163: 1723-29.
2. Bokodi G, Treszl A, Kovacs L, Tulassay T, Vasarhelyi B. Dysplasia: A review. Pediatr. Pulmonol. 2007; 42: 952-61.
3. Speer CP. Chorioamnionitis, postnatal factors and proinflammatory response in the pathogenetic sequence of bronchopulmonary dysplasia. Neonatology 2009; 95: 353-61.
4. Speer CP. Inflammation and bronchopulmonary dysplasia: A continuing story. Semin. Fetal Neonatal Med. 2006; 11: 354-62.
5. Kilpatrick DC. Mannan-binding lectin: Clinical significance and applications. Biochim. Biophys. Acta 2002; 1572: 401-13.
6. Garred P. Mannose-binding lectin genetics: from A to Z. Biochem. Soc. Trans. 2008; 36: 1461-66.
7. Eisen DP, Minchinton RM. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin. Infect. Dis. 2003; 37: 1496-505.
8. Aydemir C, Onay H, Oguz SS et al. Mannose-binding lectin codon 54 gene polymorphism in relation to risk of nosocomial invasive fungal infection in preterm neonates in the neonatal intensive care unit. J. Matern. Fetal Neonatal Med. 2011; 24: 1124-7.
9. Ozkan H, Köksal N, Cetinkaya M et al. Serum mannose-binding lectin (MBL) gene polymorphism and low MBL levels are associated with neonatal sepsis and pneumonia. J. Perinatol. 2011; 32: 210-17.
10. Casanova JL, Abel L. Human mannose-binding lectin in immunity: Friend, foe, or both? J. Exp. Med. 2004; 199: 1295-9.
11. Koroglu OA, Onay H, Erdemir G et al. Mannose-binding lectin gene polymorphism and early neonatal outcome in preterm infants. Neonatology 2010; 98: 305-12.
12. Hilgendorff A, Heidinger K, Pfeiffer A et al. Association of polymorphisms in the mannose-binding lectin gene and pulmonary morbidity in preterm infants. Genes Immun. 2007; 8: 671-7.
13. Capoluongo E, Vento G, Rocchetti S et al. Mannose-binding lectin polymorphisms and pulmonary outcome in premature neonates: A pilot study. Intensive Care Med. 2007; 33: 1787-94.
14. Arend WP. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev. 2002; 13: 323-40.
15. Witkin SS, Gerber S, Ledger WJ. Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin. Infect. Dis. 2002; 34: 204-9.
16. Ehrenkranz RA, Walsh MC, Vohr BR et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 2005; 116: 1353-60.
17. Tollner U. Early diagnosis of septicemia in the newborn. Clinical studies and sepsis score. Eur. J. Pediatr. 1982; 138: 331-7.
18. Edwards MS. Postnatal bacterial infections. In: Martin RJ, Fanaroff AA, Walsh MC (eds). Fanaroff and Martin's Neonatal-Perinatal Medicine Diseases of the Fetus and Infant, 9th edn, Vol. 2. Mosby Elsevier, St Louis, MO, 2011; 793-806.
19. Onay H, Pehlivan M, Alper S, Ozkinay F, Pehlivan S. Might there be a link between mannose binding lectin and vitiligo? Eur. J. Dermatol. 2007; 17: 146-8.
20. Ertam I, Itirli G, Onay H, Alper S, Ozkinay F. Interleukin-1 receptor antagonist and tumour necrosis factor-alpha gene polymorphisms in Turkish patients with allergic contact dermatitis. Contact Dermat. 2009; 61: 86-90.
21. Jobe AH, Ikegami M. Antenatal infection/inflammation and postnatal lung maturation and injury. Respir. Res. 2001; 2: 27-32.
22. Parton LA, Strassberg SS, Qian D, Galvin-Parton PA, Cristea IA. The genetic basis for bronchopulmonary dysplasia. Front. Biosci. 2006; 11: 1854-60.
23. Lavoie PM, Pham C, Jang KL. Heritability of bronchopulmonary dysplasia, defined according to the consensus statement of the national institutes of health. Pediatrics 2008; 122: 479-85.
24. Abman SH, Mourani PM, Sontag M. Bronchopulmonary dysplasia: A genetic disease. Pediatrics 2008; 122: 658-9.
25. Murtha AP, Nieves A, Hauser ER et al. Association of maternal IL-1 receptor antagonist intron 2 gene polymorphism and preterm birth. Am. J. Obstet. Gynecol. 2006; 195: 1249-53.
26. Chaves JH, Babayan A, Bezerra Cde M, Linhares IM, Witkin SS. Maternal and neonatal interleukin-1 receptor antagonist genotype and pregnancy outcome in a population with a high rate of pre-term birth. Am. J. Reprod. Immunol. 2008; 60: 312-17.
27. Bodamer OA, Mitterer G, Maurer W, Pollak A, Mueller MW, Schmidt WM. Evidence for an association between mannose-binding lectin 2 (MBL2) gene polymorphisms and pre-term birth. Genet. Med. 2006; 8: 518-24.
28. Kakkera DK, Siddiq MM, Parton LA. Interleukin-1 balance in the lungs of preterm infants who develop bronchopulmonary dysplasia. Biol. Neonate 2005; 87: 82-90.
29. Elsmen E, Ley D, Cilio CM, Hansen-Pupp I, Hellstrom-Westas L. Umbilical cord levels of interleukin-1 receptor antagonist and neonatal outcome. Biol. Neonate 2006; 89: 220-26.
30. Gerber S, Vardhana S, Meagher-Villemure K, Vial Y, Hohlfeld P, Witkin SS. Association between fetal interleukin-1 receptor antagonist gene polymorphism and unexplained fetal death. Am. J. Obstet. Gynecol. 2005; 193: 1472-7.
31. de Benedetti F, Auriti C, D'Urbano LE et al. Low serum levels of mannose binding lectin are a risk factor for neonatal sepsis. Pediatr. Res. 2007; 61: 325-8.
32. Frakking FN, Brouwer N, van Eijkelenburg NK et al. Low mannose-binding lectin (MBL) levels in neonates with pneumonia and sepsis. Clin. Exp. Immunol. 2007; 150: 255-62.
33. Dzwonek AB, Neth OW, Thiebaut R et al. The role of mannose-binding lectin in susceptibility to infection in preterm neonates. Pediatr. Res. 2008; 63: 680-85.